The aim of the study was to compare bone mineral density (BMD) in healthy postmenopausal women to BMD in type 2 diabetic hypertensive postmenopausal women with hyperlipidemia. Methods: Fifty type 2 diabetic and hypertensive postmenopausal women with hyperlipidemia and 51 age and body mass index (BMI) matched healthy postmenopausal women were included. Lumbar spine and femoral neck BMD were noted in both groups. BMD was measured using dual energy X-ray absorptiometry (DXA). Serum alkaline phosphatase (ALP), calcium and phosphorous were also measured. Pearson correlation coefficients were used to establish the relationship between various clinical characteristics. Results: There were no significant differences between two groups in respect to lumbar and vertebral BMD values, age, BMI, gravidity, parity. Serum cholesterol and fasting glucose levels were significantly different between each groups (P = 0.0001, P = 0.002). Conclusion: We found that, accompanying chronic diseases such as diabetes, hypertension and hyperlipidemia don't affect the BMD measurements at postmenopausal period. So these postmenopausal women don't have excess risk regarding osteoporosis. 
Introduction
Although it is generally accepted that type 1 diabetes is associated with ten percent less bone mineral density (BMD) value compared with no diabetic adults, 1, 2 there is no consensus on osteoporosis risk in people with type 2 diabetes. Nicodemus and Folsom 3 found that women with type 2 diabetes had 1.70-fold higher risk of incident hip fracture than women without diabetes. Two other studies revealed no difference in bone density between type 2 diabetes patients and control subjects. 4, 5 Some have reported higher bone mass in type 2 diabetic patients relative to no diabetic control subjects.
6~8
The aim of this study to compare the BMD values of postmenopausal women with diabetic, hypertensive and hyperlipidemic postmenopausal women
Materials and Methods
The medical records and BMD measurements of 50 diabetic hypertensive postmenopausal women followed-up at our institution for 4 years were evaluated retrospectively.
A cohort of women with known diabetes mellitus (DM) Our control group was selected from these patients. Data ). According to WHO 
Results
There were no significant differences between two groups in respect to lumbar and vertebral BMD values, age, BMI, gravidity, parity (Table 1) . Serum cholesterol and fasting glucose levels were significantly different between each groups (P = 0.0001, P = 0.002). There were no significant differences in serum ALP, calcium and phosphorous levels between the diabetic patients and the controls. There was a negative correlation between lumbar spine BMD and duration of menopause. But we didn' t find a correlation between blood glucose levels and BMD (Table 2 ). After adjusting for age and menopausal time, the partial correlation of BMD with biochemical marker levels were shown in Table 3 .
Discussion
Data regarding the impact of DM on the BMD are controversial. Studies have found that people with type 2 diabetes have increased, 6~8 similar 4,5 or decreased bone mass in comparison to healthy control subjects. 3 Although BMD measurements of femur neck and lumbar (L2-L4) spines were lower in study group. We couldn' t find significant differences between study and control group. Regarding the effect of glycaemia on BMD, there are some data that depict the relation between glycaemia and BMD. Hyperglycemia induces decreased bone turnover with osteoblast dysfunction and suppresses serum osteocalcin levels. 9, 10 According to the previous studies that defend a relation between DM and osteoporosis, osteoporosis is more frequent among chronic DM patients, who have retinopathies, neuropathies or vascular disease. 11 Kanazawa et al. 12 claimed a negative correlation between serum osteocalcin and hemoglobin A1c (HbA1c) levels. Viegas et al. 13 21 On the other hand Demir et al. 22 couldn' t find any correlation between cholesterol levels and BMD. In another study it was reported that lipid profile wasn' t a unique factor on BMD besides lipids duration of menopause and level of estrogen were also effective on BMD. 23 In our study we couldn' t find significant differences between diabetic, hyperlipidemic and hypertensive women and control group. There is expediency with literature. In our study we didn' t inquire medication among hypertensive and hyperlipidemic patients. In the literature positive effects of antihypertensive and antihyperlipidemic drugs on BMD were reported. Some previous studies reported positive effects of anti-lipid drugs on BMD. 24~26 In another study
Olmos et al. 27 reported that thiazide group drugs were effective in increasing BMD in hypertensive patients. The relation between BMD and Cardiovascular Disease risk factors such as hypertension and hyperlipidemia couldn' t be clearly defined. In another study, no relation was found between hypertension and BMD. 28, 29 There are no significant differences between study group and control group in terms of BMD measurements.
We found that, accompanying chronic diseases such as diabetes, hypertension and hyperlipidemia don' t affect the BMD measurements at postmenopausal period. So these postmenopausal women don' t have excess risk regarding osteoporosis.
